Who are TRAW's key supply-chain partners?

Traws Pharma (TRAW)'s supply-chain partners include Virom, Inc., Piper Sandler & Co.. Map every supplier, customer, and concentration risk.

What is TRAW's biggest supplier?

See Traws Pharma (TRAW) top suppliers, their share of cost of goods sold, and geographic concentration risk.

See Traws Pharma (TRAW) top customers, share of revenue, and end-market concentration risk.

$0.57

+0.02 (+4.25%)

Weekly Expected Move ±11.5%

$0 $1 $1 $1 $1

NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $8.7M mcap · 12M float · 4.83% daily turnover · Short 26% of daily vol

2 relationships

As Filer

counterparties named

As Counterparty

mentioned by others

Rel. Types

2021-08-20

Earliest Filing

2025-09-12

Latest Filing

target: 1 partner: 1

2 relationships

Companies named in TRAW's SEC 8-K filings as business counterparties.

Counterparty	Ticker	Relationship	Summary	Filing Date	SEC
Virom, Inc.	—	target	Target of asset purchase for $2,350,000 including intellectual property and pipeline assets.	2025-09-12	View
Piper Sandler & Co.	PIPR	partner	Sales agent for at-the-market equity offering program	2021-08-20	View

Recent 8-K Filings (20)

Filing Date	Description	Type	SEC
2026-08-14	Earnings Release; Regulation FD; Exhibits		View
2026-07-31	Delisting Notice		View
2026-07-10	Other Events; Exhibits		View
2026-07-09	Officer/Director Change; Shareholder Vote; Exhibits		View
2026-06-22	Regulation FD; Exhibits		View
2026-06-12	Regulation FD; Exhibits		View
2026-05-27	Regulation FD; Exhibits		View
2026-05-26	Other Events; Exhibits		View
2026-05-15	Earnings Release; Regulation FD; Exhibits		View
2026-04-15	Material Agreement; Unregistered Equity Sales; Other Events; Exhibits	Agreement	View
2026-04-15	Earnings Release; Regulation FD; Exhibits		View
2026-02-19	Other Events; Financial Statements and Exhibits		View
2026-01-26	Other Events; Financial Statements and Exhibits		View
2026-01-13	Other Events; Financial Statements and Exhibits		View
2025-12-17	Other Events; Financial Statements and Exhibits		View
2025-12-16	Departure/Election of Directors; Appointment of Officers		View
2025-11-28	Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit		View
2025-11-13	Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex		View
2025-10-17	Departure/Election of Directors; Appointment of Officers		View
2025-10-14	Other Events; Financial Statements and Exhibits		View

Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR